The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1
Open accessAbstract
Silencing gene expression by RNAi is a powerful method for exploring gene function and validating drug targets and potentially for therapy. Lymphocytes and other primary blood cells are resistant to lipid-based transfection in vitro and are difficult to target in vivo. We show here that antibody-protamine fusion proteins targeting the human integrin lymphocyte function-associated antigen-1 (LFA-1) efficiently deliver siRNAs and specifically induce silencing in primary lymphocytes, monocytes, and dendritic cells. Moreover, a fusion protein constructed from an antibody that preferentially recognizes activation-dependent conformational changes in LFA-1 selectively targets activated leukocytes and can be used to suppress gene expression and cell proliferation only in activated lymphocytes. The siRNA-fusion protein complexes do not cause lymphocyte activation or induce IFN responses. K562 cells expressing latent WT or constitutively activated LFA-1 engrafted in the lungs of SCID mice are selectively targeted by intravenously injected fusion protein–siRNA complexes, demonstrating the potential in vivo applicability of LFA-1-directed siRNA delivery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1
Dustin, M. L., & Springer, T. A. (1989) · Nature · doi:10.1038/341619a0 · Cited by 1,538
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357
Hornung, V., Guenthner-Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A., Manoharan, M., Akira, S., de Fougerolles, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1191 · Cited by 1,232
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,168
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
Song, E., Zhu, P., Lee, S.-K., Chowdhury, D., Kussman, S., Dykxhoorn, D. M., Feng, Y., Palliser, D., Weiner, D. B., Shankar, P., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1101 · Cited by 1,021
Self-citationBidirectional Transmembrane Signaling by Cytoplasmic Domain Separation in Integrins
Kim, M., Carman, C. V., & Springer, T. A. (2003) · Science · doi:10.1126/science.1084174 · Cited by 786
Self-citationProgress towards in Vivo Use of siRNAs
Behlke, M. A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.001 · Cited by 677
A Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis
Lebwohl, M., Tyring, S. K., Hamilton, T. K., Toth, D., Glazer, S., Tawfik, N. H., Walicke, P., Dummer, W., Wang, X., Garovoy, M. R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030002 · Cited by 570
Chemokines Trigger Immediate β2 Integrin Affinity and Mobility Changes
Constantin, G., Majeed, M., Giagulli, C., Piccio, L., Kim, J. Y., Butcher, E. C., & Laudanna, C. (2000) · Immunity · doi:10.1016/s1074-7613(00)00074-1 · Cited by 521
Shimaoka, M., Xiao, T., Liu, J.-H., Yang, Y., Dong, Y., Jun, C.-D., McCormack, A., Zhang, R., Joachimiak, A., Takagi, J., et al. (2003) · Cell · doi:10.1016/s0092-8674(02)01257-6 · Cited by 516
Self-citationIntegrin avidity regulation: are changes in affinity and conformation underemphasized?
Carman, C. V., & Springer, T. A. (2003) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.08.003 · Cited by 500
Self-citationSioud, M. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.03.013 · Cited by 418
The Silent Revolution: RNA Interference as Basic Biology, Research Tool, and Therapeutic
Dykxhoorn, D. M., & Lieberman, J. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104606 · Cited by 336
Self-citationTherapeutic targeting of the effector T-cell co-stimulatory molecule OX40
Sugamura, K., Ishii, N., & Weinberg, A. D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1371 · Cited by 335
Haskard, D., Cavender, D., Beatty, P., Springer, T., & Ziff, M. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.9.2901 · Cited by 242
The primacy of affinity over clustering in regulation of adhesiveness of the integrin αLβ2
Kim, M., Carman, C. V., Yang, W., Salas, A., & Springer, T. A. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200404160 · Cited by 227
Self-citationMembranes as messengers in T cell adhesion signaling
Dustin, M. L., Bivona, T. G., & Philips, M. R. (2004) · Nature Immunology · doi:10.1038/ni1057 · Cited by 225
Shimaoka, M., Lu, C., Palframan, R. T., von Andrian, U. H., McCormack, A., Takagi, J., & Springer, T. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101130498 · Cited by 209
Self-citationLeukocyte-endothelial interactions: Clinical trials of anti-adhesion therapy
Harlan, J. M., & Winn, R. K. (2002) · Critical Care Medicine · doi:10.1097/00003246-200205001-00007 · Cited by 182
Genomic Views of the Immune System
Staudt, L. M., & Brown, P. O. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.829 · Cited by 168
Lu, C., & Springer, T. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.268 · Cited by 147
The clinical potential of chemokine receptor antagonists
Ribeiro, S., & Horuk, R. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.01.004 · Cited by 120
Marodon, G., Mouly, E., Blair, E. J., Frisén, C., Lemoine, F. M., & Klatzmann, D. (2003) · Blood · doi:10.1182/blood-2002-02-0578 · Cited by 82
Petruzzelli, L., Maduzia, L. L., & Springer, T. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.2.854 · Cited by 79
Hutton, J. J., Jegga, A. G., Kong, S., Gupta, A., Ebert, C. L., Williams, S. S., Katz, J. D., & Aronow, B. J. (2004) · BMC Genomics · doi:10.1186/1471-2164-5-82 · Cited by 62
Efficient nonviral gene delivery into primary lymphocytes from rats and mice
Goffinet, C., & Keppler, O. T. (2006) · The FASEB Journal · doi:10.1096/fj.05-4651fje · Cited by 60
Gene transfection and expression in resting and activated murine CD4 T cell subsets
Lai, W., Chang, C., & Färber, D. L. (2003) · Journal of Immunological Methods · doi:10.1016/j.jim.2003.07.015 · Cited by 53
Shimaoka, M., Kim, M., Cohen, E. H., Yang, W. Y., Astrof, N. S., Peer, D., Salas, A., Ferrand, A., & Springer, T. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605716103 · Cited by 50
Self-citationLu, C., Shimaoka, M., Salas, A., & Springer, T. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3972 · Cited by 44
Self-citationA Mimic of p21WAF1/CIP1 Ameliorates Murine Lupus
Goulvestre, C., Chéreau, C., Nicco, C., Mouthon, L., Weill, B. J., & Batteux, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6959 · Cited by 40
Role of CCR5 in the Pathogenesis of IL-13-Induced Inflammation and Remodeling
Ma, B., Liu, W., Homer, R., Lee, P. J., Coyle, A. J., Lora, J. M., Lee, C. G., & Elias, J. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4968 · Cited by 34
Treating autoimmune diseases through restoration of antigen-specific immune tolerance
Wolfraim, L. A. (2006) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-006-0001-7 · Cited by 24
Cited by
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Self-citationInterfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H.-P., Maraganore, J., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,203
Self-citationA combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,150
Jackson, A. L., & Linsley, P. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3010 · Cited by 1,083
Ashley, C. E., Carnes, E. C., Phillips, G. K., Padilla, D., Durfee, P. N., Brown, P. A., Hanna, T. N., Liu, J., Phillips, B., Carter, M. B., et al. (2011) · Nature Materials · doi:10.1038/nmat2992 · Cited by 1,024
Metadata
- Authors
- Peer, D., Zhu, P., Carman, C. V., Lieberman, J., & Shimaoka, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-03-06
- Volume
- 104
- Issue
- 10
- Pages
- 4095-4100
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2124018243
- Cited by
- 275
- References
- 34
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.